|
|
Volumn 20, Issue 1, 2002, Pages 161-165
|
|
Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DNA;
DNA BINDING PROTEIN;
DOXORUBICIN;
FOLINIC ACID;
LACTATE DEHYDROGENASE;
MACOP B PROTOCOL;
MACOP-B PROTOCOL;
METHOTREXATE;
ONCOPROTEIN;
PREDNISONE;
PROTEIN BCL 6;
TRANSCRIPTION FACTOR;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
B CELL LYMPHOMA;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GENE REARRANGEMENT;
GENETICS;
HUMAN;
IMMUNOPHENOTYPING;
LARGE CELL LYMPHOMA;
MALE;
METABOLISM;
MIDDLE AGED;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
SOUTHERN BLOTTING;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BLOTTING, SOUTHERN;
CYCLOPHOSPHAMIDE;
DNA, NEOPLASM;
DNA-BINDING PROTEINS;
DOXORUBICIN;
GENE REARRANGEMENT, B-LYMPHOCYTE;
HUMANS;
IMMUNOPHENOTYPING;
L-LACTATE DEHYDROGENASE;
LEUCOVORIN;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE-CELL, DIFFUSE;
MALE;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM STAGING;
PREDNISONE;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-6;
TRANSCRIPTION FACTORS;
VINCRISTINE;
MLCS;
MLOWN;
|
|
EID: 0036133890
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.20.1.161 Document Type: Article |
|
Times cited : (33)
|
|
References (0)
|
